HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea.

AbstractBACKGROUND:
Dead Sea climatotherapy (DSC) is a highly effective treatment for psoriasis; however, there are scanty data concerning the duration of post-therapy remission.
OBJECTIVE:
Assessment of the duration of remission in patients suffering from plaque-type psoriasis after a 4-week DSC.
METHODS:
Sixty-four patients from Germany (66% men; average age: 41.5 years) underwent a 4-week course of DSC between September 2001 and November 2002. After returning home, patients were asked to inform their dermatologist immediately when new lesions appeared. In parallel, they were called every 3 months by telephone. All patients who reported new skin lesions underwent a physical examination, including a Psoriasis Assessment Severity Index (PASI).
OUTCOMES:
(1) Time of recurrence of a psoriatic lesion after complete or almost complete clearance, defined as duration of remission; (2) time that elapsed until a relapse of 50% of the PASI improvement occurred, defined as duration of therapeutic effect.
RESULTS:
Mean PASI value before and after treatment was 31.7 and 1.42, showing a 95.5% improvement. All patients reached PASI 50, and 75.9% of them reached PASI 75 after 1 month of DSC. The median time of remission was 23.1 weeks. The median time of duration of therapeutic effect was 33.6 weeks. Statistical multivariable analysis indicated that a patient's younger age at the time of treatment was associated with a longer period of remission.
CONCLUSION:
Four-week DSC is an effective remittive treatment for plaque-type psoriasis. The period of remission induced compares favorably with other accepted modalities of treatment.
AuthorsMarco Harari, Lena Novack, Joachim Barth, Michael David, Michael Friger, Shimon W Moses
JournalInternational journal of dermatology (Int J Dermatol) Vol. 46 Issue 10 Pg. 1087-91 (Oct 2007) ISSN: 0011-9059 [Print] England
PMID17910722 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Climatotherapy
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Psoriasis (pathology, therapy)
  • Quality of Life
  • Radiation Dosage
  • Recurrence
  • Severity of Illness Index
  • Treatment Outcome
  • Ultraviolet Therapy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: